HHS cancels funding for Moderna bird flu vaccine
Digest more
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,
The Trump administration’s decision to yank nearly $600 million in promised bird flu vaccine funding is the latest worrying sign for Moderna.
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Jefferies Global Health Care Conference,
For many Americans, it's not clear how easy getting a COVID-19 vaccination this fall will be — or if they've lost the choice. Health Secretary Robert F.
Explore more